Recent investigations have also suggested that genetic alterations within the CD6 gene associated with clinical outcome of several autoimmune diseases (44, 58) and correlated with the response to TNFi (59), which pointed to a role of these soluble scavenger receptors in modulating response to anti-TNF drugs. This evidence concerns the gene TNF and autoimmune disease.